Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -89.20 is 95% above its 5-year average of -1696.36, near the high end of its 5-year range (-5379.87–-24.24).
127.32% below its 12-month average of -39.24.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-07-31): -4.56.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
EARNINGS PER SHARE (EPS)
-89.20
EARNINGS PER SHARE (EPS) AVG TTM
-39.24
EARNINGS PER SHARE (EPS) AVG 3Y
-1704.73
EARNINGS PER SHARE (EPS) AVG 5Y
-1696.36
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-127.32%
CURRENT VS 3Y AVG
+94.77%
CURRENT VS 5Y AVG
+94.74%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Clearmind Medicine Inc.
Market Cap
$1.11M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.14M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$1.17M
Earnings Per Share (EPS)
N/A
TTM Avg
-76.17
3Y Avg
-936.34
5Y Avg
-837.30
Market Cap
$1.17M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
Market Cap
$1.01M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
-7.51
Market Cap
$888387.00
Earnings Per Share (EPS)
-29.09
TTM Avg
-56.46
3Y Avg
-589.82
5Y Avg
-783.52
Market Cap
$885939.00
Earnings Per Share (EPS)
-180.45
TTM Avg
-617.40
3Y Avg
-559.80
5Y Avg
-483.70
Market Cap
$897948.00
Earnings Per Share (EPS)
-1.86
TTM Avg
-3.74
3Y Avg
-18.16
5Y Avg
-24.28
Market Cap
$1.36M
Earnings Per Share (EPS)
-74.28
TTM Avg
-29.19
3Y Avg
-19.57
5Y Avg
-19.24
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clearmind Medicine Inc. (CMND) | $1.11M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | N/A | -0.03 | 0.05 | 0.05 |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | -76.17 | -936.34 | -837.30 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.17M | -19.33 | -12.55 | -11.71 | -15.69 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -8.02 | -25.27 | -9.38 | -7.51 |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | -29.09 | -56.46 | -589.82 | -783.52 |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | -180.45 | -617.40 | -559.80 | -483.70 |
| Bone Biologics Corporation (BBLG)vs › | $897948.00 | -1.86 | -3.74 | -18.16 | -24.28 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | -74.28 | -29.19 | -19.57 | -19.24 |
| Genprex, Inc. (GNPX)vs › | $1.37M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
Trailing EPS (TTM)
$-89.20
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-10-31 | -24.24 |
| 2024-10-31 | -54.24 |
| 2023-10-31 | -1360.56 |
| 2022-10-31 | -5379.87 |
| 2021-10-31 | -3054.71 |
| 2020-10-31 | -304.56 |
| 2019-10-31 | -205.04 |
| 2018-10-31 | -446.70 |
| 2017-10-31 | -13.34 |
